1. Home
  2. CANF vs JZXN Comparison

CANF vs JZXN Comparison

Compare CANF & JZXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

N/A

Current Price

$2.24

Market Cap

6.7M

Sector

Health Care

ML Signal

N/A

JZXN

Jiuzi Holdings Inc.

N/A

Current Price

$1.24

Market Cap

666.6K

ML Signal

N/A

Company Overview

Basic Information
Metric
CANF
JZXN
Founded
1994
2019
Country
Israel
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail-Auto Dealers and Gas Stations
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.7M
666.6K
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
CANF
JZXN
Price
$2.24
$1.24
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$50.00
N/A
AVG Volume (30 Days)
191.0K
63.5K
Earning Date
03-26-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2,715,455.50
N/A
Revenue Next Year
$101.06
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.17
$0.12
52 Week High
$10.40
$8.50

Technical Indicators

Market Signals
Indicator
CANF
JZXN
Relative Strength Index (RSI) 32.40 36.11
Support Level $0.17 $1.07
Resistance Level $3.59 $1.17
Average True Range (ATR) 0.15 0.06
MACD -0.07 -0.00
Stochastic Oscillator 6.25 15.00

Price Performance

Historical Comparison
CANF
JZXN

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

About JZXN Jiuzi Holdings Inc.

Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It is into trade business with a focus on sales of new energy batteries including design, commissioned processing, transportation and packaging, sales of electrical equipment, mobile phone accessories and other products. Its revenues consist of two reportable operating segments: (i) Sales of new energy batteries, including production, transportation, and packaging, in the mainland Pearl River Delta region; and(ii) Sales and production of electric vehicles in Southeast Asia, including two-wheelers, three-wheeled electric scooters, and slow-speed vehicles.

Share on Social Networks: